• [1]
    O'sullivan, L., Ross, R.P., Hill, C. (2002) Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality. Biochimie 84, 593604.
  • [2]
    Tagg, J.R., Dierksen, K.P. (2003) Bacterial replacement therapy: adapting ‘germ warfare' to infection prevention. Trends Biotechnol. 21, 217223.
  • [3]
    Hamada, S., Ooshima, T. (1975) Production and properties of bacteriocins (mutacins) from Streptococcus mutans. Arch. Oral Biol. 20, 641648.
  • [4]
    Jack, R.W., Tagg, J.R., Ray, B. (1995) Bacteriocins of gram-positive bacteria. Microbiol. Rev. 59, 171200.
  • [5]
    Caufield, P.W., Childers, N.K., Allen, D.N., Hansen, J.B. (1985) Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids. Infect. Immun. 48, 5156.
  • [6]
    Novak, J., Caufield, P.W., Miller, E.J. (1994) Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J. Bacteriol. 176, 43164320.
  • [7]
    Chikindas, M.L., Novak, J., Driessen, A.J., Konings, W.N., Schilling, K.M., Caufield, P.W. (1995) Mutacin II a bactericidal antibiotic from Streptococcus mutans. Antimicrob. Agents Chemother. 39, 26562660.
  • [8]
    Qi, F., Chen, P., Caufield, P.W. (1999) Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl. Environ. Microbiol. 65, 38803887.
  • [9]
    Qi, F., Chen, P., Caufield, P.W. (2001) The group I strain of Streptococcus mutans UA140 produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin mutacin IV. Appl. Environ. Microbiol. 67, 1521.
  • [10]
    Tagg, J.R., Bannister, L.V. (1979) Fingerprinting beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J. Med. Microbiol. 12, 397411.
  • [11]
    Crooks, M., James, S.M., Tagg, J.R. (1987) Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci. Zentralbl Bakteriol Mikrobiol Hyg[A] 263, 541547.
  • [12]
    Balakrishnan, M., Simmonds, R.S., Kilian, M., Tagg, J.R. (2002) Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages. J. Med. Microbiol. 51, 941948.
  • [13]
    Balakrishnan, M., Simmonds, R.S., Tagg, J.R. (2001) Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci. Caries Res. 35, 7580.
  • [14]
    Zinner, D.D., Jablon, J.M., Haddox, C.H., Aran, P., Saslaw, M.S. (1965) Use of fluorescent antibody technique to identify experimental hamster and rat strains of cariogenic streptococci. Proc. Soc. Exp. Bio. Med. 118, 766770.
  • [15]
    Kelstrup, J., Gibbons, R.J. (1969) Bacteriocins from human and rodent streptococci. Arch. Oral Biol. 14, 251258.
  • [16]
    Rogers, A.H. (1976) Bacteriocinogeny and the properties of some bacteriocins of Streptococcus mutans. Arch. Oral Biol. 21, 99104.
  • [17]
    Hamada, S., Ooshima, T. (1975) Inhibitory spectrum of a bacteriocin-like substance (mutacin) produced by some strains of Streptococcus mutans. J. Dent. Res. 54, 140145.
  • [18]
    Delisle, A.L. (1986) Properties of mutacin b an antibacterial substance produced by Streptococcus mutans strain BHT. Microbios 46, 2128.
  • [19]
    Delisle, A.L. (1975) Production of bacteriocins in a liquid medium by Streptococcus mutans. Antimicrob. Agents Chemother. 8, 707712.
  • [20]
    Fukushima, H., Tsuboi, Y., Fukushima, S., Sagawa, H. (1980) The elimination of bacteriocin production in the oral bacterium Streptococcus mutans. Arch. Oral Biol. 25, 767771.
  • [21]
    Balakrishnan, M., Simmonds, R.S., Carne, A., Tagg, J.R. (2000) Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin. FEMS Microbiol. Lett. 183, 165169.
  • [22]
    Netz, D.J., Bastos Mdo, C., Sahl, H.G. (2002) Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl. Environ. Microbiol. 68, 52745280.
  • [23]
    Netz, D.J., Pohl, R., Beck-Sickinger, A.G., Selmer, T., Pierik, A.J., Bastos Mdo, C., Sahl, H.G. (2002) Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. J. Mol. Biol. 319, 745756.
  • [24]
    Tauch, A., Kaiser, O., Hain, T., Goesmann, A., Weisshaar, B., Albersmeier, A., Bekel, T., Bischoff, N., Brune, I., Chakraborty, T., Kalinowski, J., Meyer, F., Rupp, O., Schneiker, S., Viehoever, P., Puhler, A. (2005) Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411 a lipid-requiring bacterium of the human skin flora. J. Bacteriol. 187, 46714682.
  • [25]
    Yonezawa, H., Kuramitsu, H.K. (2005) Genetic analysis of a unique bacteriocin Smb produced by Streptococcus mutans GS5. Antimicrob. Agents Chemother. 49, 541548.
  • [26]
    Martin, N.I., Sprules, T., Carpenter, M.R., Cotter, P.D., Hill, C., Ross, R.P., Vederas, J.C. (2004) Structural characterization of lacticin 3147 a two-peptide lantibiotic with synergistic activity. Biochemistry 43, 30493056.
  • [27]
    Brotz, H., Bierbaum, G., Leopold, K., Reynolds, P.E., Sahl, H.G. (1998) The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob. Agents Chemother. 42, 154160.
  • [28]
    Morgan, S.M., O'Connor, P.M., Cotter, P.D., Ross, R.P., Hill, C. (2005) Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob. Agents Chemother. 49, 26062611.
  • [29]
    Dougherty, B.A., Hill, C., Weidman, J.F., Richardson, D.R., Venter, J.C., Ross, R.P. (1998) Sequence and analysis of the 60 kb conjugative bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147. Mol. Microbiol. 29, 10291038.
  • [30]
    Navaratna, M.A., Sahl, H.G., Tagg, J.R. (1999) Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect. Immun. 67, 42684271.
  • [31]
    Holo, H., Jeknic, Z., Daeschel, M., Stevanovic, S., Nes, I.F. (2001) Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology 147, 643651.